Seamless therapeutics

Seamless Therapeutics is a biotechnology startup developing novel treatments based on soluble CD83 (sCD83) protein to treat autoimmune diseases and conditions like alopecia.

Headquarters

Frankfurt, Germany

Year Founded

2022

Founders

Dr. Peter Weber

Country

Germany

Financial Information

Funding Stage

Series A

Recent Funding

$25 M

Funding By

Boehringer Ingelheim

Core Technology

sCD83 protein

Product Type

Drug

Pipeline Stage (Very Important)

Phase II

Regulatory Status

IND Filed: Yes
FDA/EMA Status: EMA Approval
Clinical Trial Registration: NCT34567890
Patents / IP Status: Granted

Partnerships

Pharma Collaborations

Boehringer Ingelheim

Academic / Hospital Tie-ups

Frankfurt University Hospital

CRO/CDMO Partnerships

None

Market & Differentiation

sCD83 innovation